review Open AccessTop 1% cited
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Hepatology · 2017 · Vol. 67(1) · pp. 123–133
Chris Estes✉(Center for Disease Analysis)Homie Razavi(Center for Disease Analysis)Rohit Loomba(University of California San Diego)Zobair M. Younossi(Inova Fairfax Hospital)Arun J. Sanyal(Virginia Commonwealth University)
Abstract
With continued high rates of adult obesity and DM along with an aging population, NAFLD-related liver disease and mortality will increase in the United States. Strategies to slow the growth of NAFLD cases and therapeutic options are necessary to mitigate disease burden. (Hepatology 2018;67:123-133).
Liver Disease Diagnosis and TreatmentLiver Disease and TransplantationDiet, Metabolism, and DiseaseNonalcoholic fatty liver diseaseMedicineCirrhosisInternal medicinePopulationLiver transplantationIncidence (geometry)Hepatocellular carcinomaGastroenterologyLiver disease
MeSH terms
AdultAgedFemaleHumansLiver NeoplasmsMaleMarkov ChainsMiddle AgedSeverity of Illness IndexUnited StatesPrevalenceSurvival AnalysisHealth Care CostsCost of IllnessAge Distribution
Funding
- Bristol-Myers Squibb
- Gilead Sciences
- Intercept Pharmaceuticals
Citations
2,339
FWCI
92.67
field-weighted impact
References
48
Percentile
100%
vs. same field & year
Citations per year
Cited by
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
Hepatology · 2023 · 2,046 citations
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Cells · 2020 · 1,137 citations
Burden of liver diseases in the world
Journal of Hepatology · 2018 · 3,618 citations
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
Journal of Hepatology · 2018 · 1,972 citations
Complications, morbidity and mortality of nonalcoholic fatty liver disease
Metabolism · 2020 · 529 citations
Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association
Arteriosclerosis Thrombosis and Vascular Biology · 2022 · 596 citations
Mechanisms of NAFLD development and therapeutic strategies
Nature Medicine · 2018 · 4,074 citations
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
Journal of Hepatology · 2019 · 2,150 citations
References
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
Alimentary Pharmacology & Therapeutics · 2011 · 3,085 citations
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Hepatology · 2012 · 3,804 citations
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Gastroenterology · 2005 · 2,883 citations
Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
Gastroenterology · 2014 · 1,809 citations
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
Gastroenterology · 2010 · 2,160 citations
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Hepatology · 2005 · 10,531 citations
Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
Digestive Diseases and Sciences · 2013 · 298 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.